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Abstract
Background: To update appropriateness ratings for carotid endarterectomy using the best clinical
evidence and to develop a tool to audit the procedure's use.
Methods: A nine-member expert panel drawn from all the Canadian Specialist societies that are
involved in the care of patients with carotid artery disease, used the RAND Appropriateness
Methodology to rate scenarios where carotid endarterectomy may be performed. A 9-point rating
scale was used that permits the categorization of the use of carotid endarterectomy as appropriate,
uncertain, or inappropriate. A descriptive analysis was undertaken of the final results of the panel
meeting. A database and code were then developed to rate all carotid endarterectomies performed
in a Western Canadian Health region from 1997 to 2001.
Results:  All scenarios for severe symptomatic stenosis (70–99%) were determined to be
appropriate. The ratings for moderate symptomatic stenosis (50–69%) ranged from appropriate to
inappropriate. It was never considered appropriate to perform endarterectomy for mild stenosis
(0–49%) or for chronic occlusions. Endarterectomy for asymptomatic carotid disease was thought
to be of uncertain benefit at best. The majority of indications for the combination of
endarterectomy either prior to, or at time of coronary artery bypass grafting were inappropriate.
The audit tool classified 98.0% of all cases.
Conclusions: These expert panel ratings, based on the best evidence currently available, provide
a comprehensive and updated guide to appropriate use of carotid endarterectomy. The resulting
audit tool can be downloaded by readers from the Internet and immediately used for hospital audits
of carotid endarterectomy appropriateness.
Background
Evidence for efficacy of an intervention may be clearly
established, but its expected effectiveness outside of a clin-
ical trial setting, the values of decision makers, and
resources available at a given point in time may all affect
how that intervention is brought into generalized clinical
care [1]. These may vary across different countries and
decision-makers and this may lead to different
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interpretations of the evidence [2-5]. Hence different cri-
teria, guidelines and appropriateness ratings often need to
be developed in different countries, which may then guide
the clinical audit of interventions and outcomes.
The first appropriateness study on the use of carotid
endarterectomy (CE), prompted by concerns of its unnec-
essary use, suggested that only a third of CE procedures
were appropriate [6]. It was published in 1988, prior to
the large randomized controlled trials [7-10] that provide
our current evidence base for the majority of indications
for this procedure. In spite of the proliferation of the high-
est level of evidence available to guide patient manage-
ment, controversy still exists as to what constitutes
appropriate use of the procedure, especially in those with
asymptomatic disease [11,12]. This may explain some of
the marked variation in the rate of usage of CE between
countries and regions [13,14].
The objectives of this paper were: firstly, to describe the
development of contemporary appropriateness ratings for
carotid endarterectomy according to a panel of Canadian
experts; and secondly, to develop an audit tool for chart
review based on these ratings. The ratings generated from
this process are likely to be of particular relevance to
health systems that resemble Canada's single payer sys-
tem, and the tolls that we provide will facilitate the con-
duct of CE appropriateness audits as a means of ensuring
optimal utilization of this procedure.
Methods
Appropriateness methodology
The RAND/ UCLA Appropriateness methodology has
been described in depth elsewhere [1,2,15-18]. In brief, a
comprehensive literature review is conducted collecting
all available evidence for a given diagnostic or therapeutic
intervention. A set of scenarios is developed covering all
possible clinical situations under which that intervention
might be performed. A panel of experts is asked to inde-
pendently rate each scenario guided by the evidence pre-
sented. The rating scale ranges from 1 to 9; 1 to 3
indicating an inappropriate indication, 4 to 6 an uncer-
tain indication, and 7 to 9 an appropriate indication. (For
all definitions see Appendix) These initial ratings are col-
lated. The panel is then convened and the participants
provided with their initial rating and the median rating of
the group for each scenario. Under the guidance of a chair,
the group discusses each scenario with the relevant evi-
dence and individually re-rates each scenario. The median
of these final ratings is used to determine the appropriate-
ness of each scenario according to the schema as pre-
sented above. Given that none of the scenarios, provoked
disagreement among the panellists according to the
RAND definition this played no role in the allocation of
appropriateness.
The Medline database was used as the primary route for
searching for relevant material for the literature review for
this study. Evidence was rated as described elsewhere [19].
Where evidence was available for a given indication from
randomized controlled trials, no further literature was
presented. If this level of evidence was unavailable, litera-
ture from the next available evidence hierarchy was
presented.
The nine panel members were selected from nominations
made by presidents of the various Canadian national soci-
eties representing stroke neurology (two members), neu-
rosurgery (two), vascular surgery (two), internal medicine
(one), family medicine (one) and neuroradiology (one).
The consensus conference proceedings were taped and
transcribed.
Analyses
A descriptive analysis of the final appropriateness ratings
of both symptomatic and asymptomatic stenoses by
degree of internal carotid artery stenosis was performed.
For all scenarios in this analysis, conventional angiogra-
phy was the imaging modality assumed to have deter-
mined the degree of stenosis. The transcribed discussions
of the panel were used to help to identify the 'key ele-
ments of reasoning' behind the panel's decisions. These
'key elements of reasoning' are presented in narrative
form in the text of the Results section to accompany the
quantitative reporting on panel ratings for the clinical
scenarios.
A Microsoft Access® Database was developed to enable
easy collection of the necessary clinical data to determine
appropriateness from patient charts. Data can be entered
directly into this database. In parallel, we developed an
algorithm written in SAS version 8 for transforming the
raw data gathered from chart review to final appropriate-
ness ratings. We make both the Microsoft Access® Data-
base and the SAS code available for download from the
Internet [20].
A reviewer used the database to collect the clinical data by
chart review on all carotid endarterectomies performed in
the Calgary Health Region in the period of 1997 – 2001,
a total of 801 cases. The data collected were then run with
the SAS code and its ability to classify the cases tested.
Results and Discussion
Symptomatic carotid stenosis
The final appropriateness ratings for symptomatic inter-
nal carotid artery stenoses are summarised in Table 1. The
ratings for severe (70 – 99%) symptomatic stenosis are the
highest of any group. The panel felt that a majority of
patients will benefit from treatment, because the magni-
tude of benefit conferred by surgery over medicalBMC Health Services Research 2004, 4:17 http://www.biomedcentral.com/1472-6963/4/17
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treatment [2] has been shown to be so great that the pro-
cedure is likely to be of benefit even when performed by
surgeons with a higher complication rate than in the trials.
Appropriateness ratings ranged from appropriate to inap-
propriate for moderate (50 – 69%) symptomatic stenosis.
This reflected the reduced margin of benefit for CE when
compared to severe stenosis in the trials [3,4], and the
higher surgical complication rates seen in real-life practice
[21]. Remote transient events, either hemispheric or reti-
nal, and early operation after moderate stroke were con-
sidered to be of uncertain benefit. The presence of a
contralateral occluded artery tended to lead to an indica-
tion being deemed less appropriate.
Table 1: Final appropriateness ratings for carotid endarterectomy for symptomatic stenosis by degree of stenosis.
Degree of Stenosis Indication Comments Appropriateness Rating
Severe (70 – 99%) Hemispheric TIA Any indication, surgery performed at any time up to 
2 years
Appropriate
Retinal TIA Any indication, surgery performed at any time up to 
2 years
Appropriate
Mild Stroke Any indication, surgery performed at any time up to 
2 years
Appropriate
Moderate Stroke Any indication, surgery performed at any time up to 
2 years
Appropriate
Stroke in Evolution Uncertain
Moderate (50 – 69%) Hemispheric TIA Single, multiple, crescendo events within the last 
180 days with contralateral stenosis +/- ulcerated 
stenosis
Appropriate
Single event with contralateral occlusion or event 
6–24 months ago
Uncertain
Retinal TIA Multiple events, single event within 180 days with 
contralateral stenosis
Appropriate
All other indications Uncertain
Mild Stroke Any indication, surgery performed at any time up to 
2 years
Appropriate
Moderate Stroke Any indication >3 weeks following event, <3 weeks 
only in presence of contralateral stenosis
Appropriate
All other indications Uncertain
Stroke in Evolution Inappropriate
Mild (0 – 49%) Hemispheric TIA Crescendo or single events associated with 
ulcerated stenosis
Uncertain
All other indications Inappropriate
Hemispheric/ Retinal TIA 
where refractory to medical 
treatment
Multiple events associated with ulcerated stenosis Uncertain
All other indications Inappropriate
Retinal TIA All indications Inappropriate
Mild Stroke All indications Inappropriate
Moderate Stroke All indications Inappropriate
Stroke in Evolution All indications Inappropriate
Acute Occlusion Hemispheric TIA Uncertain
Retinal TIA Multiple events Uncertain
Single event Inappropriate
Mild/ Moderate Stroke Uncertain
Chronic Occlusion Any Indication Inappropriate
Vertebro-basilar TIA 70% stenosis associated with severe incorrectable 
vertebrobasilar disease
UncertainBMC Health Services Research 2004, 4:17 http://www.biomedcentral.com/1472-6963/4/17
Page 4 of 7
(page number not for citation purposes)
CE for those with mild (0–49%) stenoses was never rated
as appropriate. Indications thought to be of uncertain
benefit were multiple or crescendo hemispheric TIAs in
association with an ulcerated plaque. The evidence show-
ing that the presence of a symptomatic, irregular plaque
was associated with a higher risk of recurrent stroke was a
major factor that guided the panel in this decision [22].
However, there was a disparity of opinion among panel-
lists, which did not meet the RAND definition of disagree-
ment, as to rating of these particular indications,
displaying the concerns raised by unplanned subanalyses
of randomized controlled trials, which may be misleading
[23].
Symptomatic acute occlusions were rated as borderline
uncertain/ inappropriate, whereas operating on a chronic
occlusion was always deemed inappropriate. The differ-
ence between these two indications relates to the limited
evidence from case series showing the possibility of
improvement in outcome from stroke with emergency
endarterectomy for acute occlusion [24].
Asymptomatic carotid stenosis
Table 2 shows the final appropriateness ratings for asymp-
tomatic internal carotid artery stenosis. For asymptomatic
stenoses less than 60%, all agreed that CE was inappropri-
ate. There was a wide range of opinion on the ratings for
endarterectomy for stenosis greater than 60% and the
scores changed considerably between the two rating ses-
sions, moving from borderline appropriate to a final rat-
ing of uncertain benefit. Only the rating of severe
asymptomatic stenosis with brain infarct present on brain
imaging approached the definition but did not meet the
RAND definition of disagreement. Otherwise only a single
rater viewed these scenarios as an appropriate. This relates
to concerns with the generalization of the results of the
Asymptomatic Carotid Atherosclerosis Study (ACAS) [5].
The rate of stroke and/or death in the surgical group of
that trial was 2.3%. Case series have been unable to match
this exceptionally low complication rate, with rates rang-
ing from 2.5% [25] to 5.6% [26]. Most of the panel felt
that in real life the marginal benefit seen in the ACAS trial
would not be seen in real life. However, in view of the pos-
itive randomized trial evidence, they felt that at worst this
be rated as an uncertain indication. It was felt that the
results of the then ongoing Asymptomatic Carotid Surgery
Trial would help to resolve the place of carotid
endarterectomy for asymptomatic stenosis.
Carotid endarterectomy associated with coronary artery 
bypass grafting
Table 3 shows the final appropriateness ratings where
carotid endarterectomy is performed either with or prior
to coronary artery bypass grafting. The imperative to com-
bine procedures is derived from anecdotal experience that
those patients with asymptomatic carotid stenosis are at
higher risk of stroke following coronary artery bypass
grafting. However, case series in the literature both sup-
port and refute this [27-30]. The panel discussed a report
that the combination of both procedures in a recent large
case series appeared to put patients at an unacceptable risk
of stroke or death (17.4%) [22]. Therefore, in all but the
highest degree of asymptomatic stenosis, the panel
thought it was an inappropriate indication for surgery,
and even in that situation, an uncertain indication only.
Performance of the appropriateness rating algorithm
Of the 801 CE cases examined, 145 (18.1%) were per-
formed for asymptomatic carotid stenosis. When these
data were run with the Access database and SAS code that
we developed, 541 were deemed appropriate (67.5%), 61
inappropriate (7.6%), 175 uncertain (21.9%). The most
common reasons for inappropriate CE were as follows:
asymptomatic stenosis less than 60% (28 cases), presence
of concurrent medical co-morbidity (dementia, recent
myocardial infarction) (18 cases), symptomatic stenosis
<50% (five cases), and chronic occlusion (eight cases).
Only 24 cases (3%) were not classified. The reasons for
the unclassified cases are as follows: no carotid artery
imaging results available (thirteen cases), no information
available regarding the degree of contralateral carotid
artery stenosis in the presence of a moderate symptomatic
stenosis (five cases), endarterectomy ipsilateral to ischae-
mic symptoms or side not identified (six cases).
Conclusions
The current study involved an all-Canadian panel of
experts from the whole spectrum of specialties (Family
Medicine, Internal Medicine, Neuroradiology, Neurology,
Neurosurgery and Vascular Surgery) that are involved in
the care of patients with carotid artery disease. Ratings of
a balanced panel have been shown to reflect the opinion
in the broader physician community [31] and to avoid the
bias inherent in having only practitioners of the interven-
tion doing the rating [12]. Each panellist was nominated
by his/her respective specialty society and represented
Canada geographically well with panellists from Nova
Scotia to British Columbia. Their interpretation of the evi-
dence could therefore be expected to have included a rep-
resentative view of the current values and resource
implications of the Canadian healthcare system.
These ratings identify ongoing areas of uncertainty that
could be used to identify priority areas for research. The
combination of coronary artery bypass grafting in associ-
ation with carotid endarterectomy requires further close
examination, especially given the high complication rates
seen in the Multistate utilization study [21]. CE for
asymptomatic carotid stenosis remains an area of uncer-BMC Health Services Research 2004, 4:17 http://www.biomedcentral.com/1472-6963/4/17
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tainty. Hopefully, the completed Asymptomatic Carotid
Surgery Trial will shed further light on the efficacy of CE
for asymptomatic disease, but it may be that further work
is merited to risk stratify those for whom CE is appropri-
ate. The ratings presented here, however, represent the
Canadian viewpoint on the decision to perform CE for
asymptomatic carotid disease until the Asymptomatic
Carotid Surgery Trial is published. These will remain valid
in determining the appropriateness of all CE performed
prior to the date of its publication and for some time after-
ward, until clinical experts and guideline-producing bod-
ies fully reappraise the role of CE in asymptomatic carotid
disease after the new trial's publication.
This ongoing area of uncertainty with regard to CE for
asymptomatic internal carotid artery stenosis led to the
conservative ratings of this Canadian Panel, rating it an
intervention of uncertain benefit at best. This is in keeping
with international opinion leaders [12]. In contrast, this is
discrepant from guidelines [32], appropriateness reviews
[33-35] and practice patterns [20,36] from the United
States, where the approach toward asymptomatic disease
is more aggressive with surgical intervention being seen as
standard of care. The synthesis of the evidence by this
panel in the form of the appropriateness ratings may
therefore be of considerable value to clinicians and policy-
makers in health care systems that resemble Canada's sin-
gle payer system, as opposed to the more procedurally
aggressive American system.
Perhaps most importantly, this paper provides access to
downloadable audit tools that readers can use to rapidly
implement carotid endarterectomy appropriateness
audits in their own clinical setting [20]. Both the data col-
lection template and accompanying SAS code are easy to
use, and will enable interested parties to perform such CE
appropriateness work to compare their local standards of
care with the latest Canadian interpretation of the availa-
ble evidence.
Appendix
Definitions
Appropriate – where a procedure is worth doing if the
expected medical benefit to the patient (health status,
quality of life, longevity) exceeds the expected negative
consequences to the patient (pain, disability, risk of
death).
Inappropriate – where a procedure should not be per-
formed if the expected negative consequences to the
patient exceeds the expected medical benefit to the
patient.
Uncertain – where the net result of a procedure's expected
medical benefit and negative consequences are equivocal.
Agreement – scenarios where no more than two of the rat-
ings are outside of the 3-point region containing the
median result.
Disagreement – scenarios where three or more readings
are in the 1-to-3 region and three or more readings are in
the 7-to-9 regions.
Table 2: Final appropriateness ratings for carotid endarterectomy for asymptomatic stenosis by degree of stenosis.
Degree of Stenosis Comments Appropriateness Rating
80 – 99% All indications Uncertain
60 – 79% All indications Uncertain
<60% All indications Inappropriate
Table 3: Final appropriateness ratings for carotid endarterectomy combined with coronary artery bypass grafting (CABG) for 
asymptomatic stenosis by degree of stenosis.
Degree of Stenosis Combined Procedure or Prior 
to CABG
Infarct on Brain Imaging Appropriateness Rating
80 – 99% Combined Present/ Absent Uncertain
Prior Present Uncertain
Absent Inappropriate
60 – 79% Combined/ Prior Present/ Absent Inappropriate
<60% Combined/ Prior Present/ Absent InappropriateBMC Health Services Research 2004, 4:17 http://www.biomedcentral.com/1472-6963/4/17
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Scenario definitions
Asymptomatic carotid artery stenosis – Carotid stenosis
that has been identified through imaging, which on thor-
ough history and examination has no ascribable
symptoms.
Symptomatic carotid artery stenosis – Carotid artery ste-
nosis, which has been identified following either transient
monocular blindness (retinal TIA) or retinal infarction, or
transient cerebral ischemia (hemispheric TIA) or stroke.
Crescendo TIA – recurrent transient cerebral or retinal
ischaemia in the distribution of the carotid artery, charac-
terized by a definite change in pattern, such as, (1)
increased frequency, multiple episodes in a single day,
over several days, or a cluster of spells over the course of
several days, (2) increased duration, that is, spells lasting
longer than the primary event, or several hours in dura-
tion, or (3) increased severity, that is, spread in the distri-
bution of ischaemia with greater or new motor, sensory,
speech, or visual defects.
Multiple TIA – multiple TIAs that do not match the defi-
nition of crescendo TIAs.
Moderate stroke – corresponds to a disability of 3,4 or 5
on the modified Rankin Scale.
Mild stroke – corresponds to a disability of 1 or 2 on the
modified Rankin Scale.
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